Posted by Michael Wonder on 28 May 2024
The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study
27 May 2024 - The Patented Medicine Prices Review Board (PMPRB), the agency that regulates the prices of patented medicines in Canada, published proposed amendments to the regulatory framework in December 2017.
Because of a series of changes and delays, the revised policy has not yet been finalised. We sought to evaluate the potential early impact of the uncertainty about the PMPRB policy on patented-medicine launches.
